← Browse by Condition
Medical Condition

b cell lymphoma refractory

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07321301 Phase 2
Recruiting

Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia

Enrollment
10 pts
Location
China
Sponsor
Daihong Liu
View Trial →
NCT06552559 Phase 1, Phase 2
Recruiting

Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma

Enrollment
37 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →